Orphazyme A/S (OZYMF)

USD 90.0

(0.0%)

Annual Income Statements

(In DKK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - 36.19 Million - - -
Cost of Revenue - 782 Thousand 2.76 Million 854.6 Thousand 571.12 Thousand 1.36 Million
Gross Profit - -782 Thousand 33.42 Million -854.6 Thousand -571.12 Thousand -1.36 Million
Operating Expenses 27.04 Thousand 40.45 Million 9.98 Million 99.17 Million 49.89 Million 230.28 Million
Selling, General and Administrative Expenses 12.88 Thousand 40.45 Million 9.98 Million 40.45 Million 7.48 Million 35.05 Million
Research and Development Expenses - - 229.94 Million 58.72 Million 42.4 Million 195.23 Million
Other Expenses 14.15 Thousand - - - - -
Cost and Expenses 27.04 Thousand 41.24 Million 12.75 Million 100.03 Million 50.46 Million 231.65 Million
Operating Income -27.04 Thousand -41.24 Million -12.75 Million -100.03 Million -50.46 Million -231.65 Million
Interest Expense - - 9.45 Million 14.11 Million 4.8 Million 2.82 Million
Income Tax Expense - -2.75 Million -755.16 Thousand -314.78 Thousand -826.19 Thousand -5.5 Million
Earnings before Tax -26.04 Thousand -41.05 Million -12.75 Million -104.4 Million -51.52 Million -235.1 Million
Net Income -26.04 Million -110.59 Million -95.75 Million -104.09 Million -50.69 Million -229.6 Million
Earnings Per Share Basic -0.00 -3135.73 -2741.89 -3669.62 -2534.65 -11.5 Thousand
Earnings Per Share Diluted -0.00 -3135.73 -2741.89 -3669.62 -2534.65 -11.5 Thousand
Weighted Average Shares Outstanding 35 Million 35.26 Thousand 34.92 Thousand 28.36 Thousand 20 Thousand 19.96 Thousand
Weighted Average Shares Outstanding (Diluted) 35.31 Million 35.26 Thousand 34.92 Thousand 28.36 Thousand 20 Thousand 19.96 Thousand
Gross Margin - - 0.92 - - -
EBIT Margin - - -0.28 - - -
Profit Margin - - -2.65 - - -
EBITDA -12.1 Thousand -40.45 Million -603.91 Million -603.44 Million -331.91 Million -230.28 Million
Earnings Before Tax Margin - - -0.35 - - -

Income Statement Charts